Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre Randomised Controlled Double-blinded Trial of BCG and Interferon Alpha in High Risk Superficial Bladder Cancer

NCT00330707 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT00330707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00330707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre Randomised Controlled Double-blinded Trial of BCG and Interferon Alpha in High Risk Superficial Bladder Cancer
Lead sponsor
National University Hospital, Singapore
Phase
Phase 2/3
Overall status
Completed
Start date
October 31, 1995
Completion date
June 30, 2005
Enrollment
140
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma of urinary bladder, superficial